Cryo-Cell International (NASDAQ:CCEL) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 40.91 percent increase over losses of $(0.22) per share from the same period last year. The company reported quarterly sales of $7.843 million which beat the analyst consensus estimate of $7.731 million by 1.45 percent. This is a 2.25 percent decrease over sales of $8.024 million the same period last year.